Sign in to view content

Port Delivery System With Ranibizumab: Key Outcomes From the Ladder Phase 2 Trial That Supported Archway Phase 3 Study Design

Arshad M. Khanani, MD, MA, FASRS

Video
Published 2019

Arshad M. Khanani, MD

AMD Neovascular Part II Symposium

Related

Dual Targeting VEGF/Ang3 Surrobody in an Experimental Model of Neovascularization
Jeffrey L. Olson, MD
Annual Meeting Talks
2019
Episode 176: Journal Club with Drs. Ferhina and M. Ali Khan discussing Preoperative Anti-VEGF, RD after Intravitreal Injection, and Influence of CATT Trial Results
Jayanth Sridhar, MD
Member Podcasts
2019
What Happens to Diabetic Retinopathy Severity Scores With Less Aggressive Treatment? A Post Hoc Analysis of the RISE and RIDE Open Label Extension Study
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2019

Category: AMD-Neovascular

See more